Toric intraocular lens vs. peripheral corneal relaxing inci- sions to correct astigmatism in eyes undergoing cataract surgery.

眼科学报 Pub Date : 2014-12-01
Zhiping Liu, Xiangyin Sha, Xuanwei Liang, Zhonghao Wang, Jingbo Liu, Danping Huang
{"title":"Toric intraocular lens vs. peripheral corneal relaxing inci- sions to correct astigmatism in eyes undergoing cataract surgery.","authors":"Zhiping Liu,&nbsp;Xiangyin Sha,&nbsp;Xuanwei Liang,&nbsp;Zhonghao Wang,&nbsp;Jingbo Liu,&nbsp;Danping Huang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To compare toric intraocular lens implantation (Toric-IOL) with peripheral corneal relaxing incisions (PCRIs) for astigmatism correction in patients undergoing cataract surgery.</p><p><strong>Methods: </strong>54 patients (54 eyes) with more than 0.75 diopter (D) of preexisting corneal astigmatism were classified as group A (0.75-1.50D) or group B (1.75-2.50D). The patients were randomized to undergo Toric-IOL or PCRIs in the steep axis with spherical IOL implantation. LogMAR uncorrected visual acuity (LogMAR UCVA), LogMAR best corrected visual acuity (LogMAR BCVA), error of vector (|EV|), surgery induced refraction correction (|SIRC|), and correction rates (CR) were measured 1 month and 6 months postoperatively.</p><p><strong>Results: </strong>At 6 months postoperatively, all 54 eyes had LogMAR BCVA ≤ 0.2. Patients who underwent PCRIs and Toric-IOL with LogMAR BCVA ≤ 0.1 showed no significant differences in group A (P = 1.00) or in group B (P = 0.59). Group A showed no significant differences in LogMAR UCVA (P = 0.70), |EV| (P = 0.13), |SIRC| (P = 0.71), and CR (P = 0.56) in patients underwent PCRIs and Toric-IOL. However, group B showed significant differences in LogMAR UCVA (P < 0.01), |EV| (P < 0.01)), |SIRC| (P < 0.01), and CR (P < 0.01). The LogMAR UCVA and |EV| between 1 and 6 months showed no significant differences in patients in group A. However, in group B, they are significant differences.</p><p><strong>Conclusion: </strong>The efficacy and stability of Toric-IOL and PCRIs were equal in low astigmatic patients. Toric-IOL achieved an enhanced effect over PCRIs in higher astigmatic patients. PCRIs had the more refractive regression than Toric-IOL in 6 months.</p>","PeriodicalId":12096,"journal":{"name":"眼科学报","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"眼科学报","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To compare toric intraocular lens implantation (Toric-IOL) with peripheral corneal relaxing incisions (PCRIs) for astigmatism correction in patients undergoing cataract surgery.

Methods: 54 patients (54 eyes) with more than 0.75 diopter (D) of preexisting corneal astigmatism were classified as group A (0.75-1.50D) or group B (1.75-2.50D). The patients were randomized to undergo Toric-IOL or PCRIs in the steep axis with spherical IOL implantation. LogMAR uncorrected visual acuity (LogMAR UCVA), LogMAR best corrected visual acuity (LogMAR BCVA), error of vector (|EV|), surgery induced refraction correction (|SIRC|), and correction rates (CR) were measured 1 month and 6 months postoperatively.

Results: At 6 months postoperatively, all 54 eyes had LogMAR BCVA ≤ 0.2. Patients who underwent PCRIs and Toric-IOL with LogMAR BCVA ≤ 0.1 showed no significant differences in group A (P = 1.00) or in group B (P = 0.59). Group A showed no significant differences in LogMAR UCVA (P = 0.70), |EV| (P = 0.13), |SIRC| (P = 0.71), and CR (P = 0.56) in patients underwent PCRIs and Toric-IOL. However, group B showed significant differences in LogMAR UCVA (P < 0.01), |EV| (P < 0.01)), |SIRC| (P < 0.01), and CR (P < 0.01). The LogMAR UCVA and |EV| between 1 and 6 months showed no significant differences in patients in group A. However, in group B, they are significant differences.

Conclusion: The efficacy and stability of Toric-IOL and PCRIs were equal in low astigmatic patients. Toric-IOL achieved an enhanced effect over PCRIs in higher astigmatic patients. PCRIs had the more refractive regression than Toric-IOL in 6 months.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
环形人工晶状体与周围角膜松弛切口在白内障手术中矫正散光的比较。
目的:比较环形人工晶状体植入术(toric - iol)与角膜周围放松切口(PCRIs)在白内障术后散光矫正中的应用效果。方法:将54例(54只眼)既往角膜散光屈光度大于0.75的患者分为A组(0.75 ~ 1.50D)和B组(1.75 ~ 2.50D)。患者随机接受Toric-IOL或陡轴pcri,并植入球形IOL。术后1个月和6个月分别测量LogMAR未矫正视力(LogMAR UCVA)、LogMAR最佳矫正视力(LogMAR BCVA)、视矢量误差(|EV|)、手术诱导屈光矫正(|SIRC|)和矫正率(CR)。结果:术后6个月,54只眼LogMAR BCVA均≤0.2。在LogMAR BCVA≤0.1的PCRIs和Toric-IOL患者中,A组(P = 1.00)和B组(P = 0.59)差异无统计学意义。A组PCRIs和Toric-IOL患者的LogMAR UCVA (P = 0.70)、|EV| (P = 0.13)、|SIRC| (P = 0.71)、CR (P = 0.56)差异均无统计学意义。B组LogMAR UCVA (P < 0.01)、|EV| (P < 0.01)、|SIRC| (P < 0.01)、CR (P < 0.01)差异均有统计学意义。a组患者1 ~ 6个月的LogMAR UCVA和|EV|差异无统计学意义,而B组患者差异有统计学意义。结论:在低散光患者中,Toric-IOL与PCRIs的疗效和稳定性相当。在高度散光患者中,Toric-IOL的效果优于PCRIs。6个月后,PCRIs的屈光退化程度高于Toric-IOL。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
1312
期刊介绍: Eye science was founded in 1985. It is a national medical journal supervised by the Ministry of Education of the People's Republic of China, sponsored by Sun Yat-sen University, and hosted by Sun Yat-sen University Zhongshan Eye Center (in October 2020, it was changed from a quarterly to a monthly, with the publication number: ISSN: 1000-4432; CN: 44-1119/R). It is edited by Ge Jian, former dean of Sun Yat-sen University Zhongshan Eye Center, Liu Yizhi, director and dean of Sun Yat-sen University Zhongshan Eye Center, and Lin Haotian, deputy director of Sun Yat-sen University Zhongshan Eye Center, as executive editor. It mainly reports on new developments and trends in the field of ophthalmology at home and abroad, focusing on basic research in ophthalmology, clinical experience, and theoretical knowledge and technical operations related to epidemiology. It has been included in important databases at home and abroad, such as Chemical Abstract (CA), China Journal Full-text Database (CNKI), China Core Journals (Selection) Database (Wanfang), and Chinese Science and Technology Journal Database (VIP).
期刊最新文献
Uveitis secondary to cancer therapeutics Optical coherence tomography angiography of non-exudative choroidal neovascularization. Application of visual electrophysiology for the diagnosis and treatment of cataracts. Intravitreal aflibercept for rubeosis iridis secondary to proliferative diabetic retinopathy. Approved pharmacotherapy for myopic choroidal neovascularization: a review of randomized controlled trials in ranibizumab and aflibercept.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1